Steven Boyd, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 3,300 shares at $3.77 ($14K) on 2020-09-18, disclosed to the SEC on 2020-09-22.
Open-market purchase of $14k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.77 | 2,000 | $8K | 55.3% |
| 2 | $4.45 | 300 | $1K | 9.8% |
| 3 | $4.77 | 1,000 | $5K | 35.0% |
| Total | $4.13 avg | 3,300 | $14K | 100% |
| Filing → |
| AVTX | BUY | 2022-01-14 | $451K | — | Filing → |
| CERC | BUY | 2021-08-18 | $194K | — | Filing → |
| EYEG | SELL | 2021-07-29 | $27.9M | — | Filing → |